Successful treatment of cerebral aspergillosis with a high oral dose of itraconazole after excisional surgery
被引:25
|
作者:
Imai, T
论文数: 0引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, JapanSapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
Imai, T
[1
]
Yamamoto, T
论文数: 0引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, JapanSapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
Yamamoto, T
[1
]
Tanaka, S
论文数: 0引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, JapanSapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
Tanaka, S
[1
]
Kashiwagi, M
论文数: 0引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, JapanSapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
Kashiwagi, M
[1
]
Chiba, S
论文数: 0引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, JapanSapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
Chiba, S
[1
]
Matsumoto, H
论文数: 0引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, JapanSapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
Matsumoto, H
[1
]
Uede, T
论文数: 0引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, JapanSapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
Uede, T
[1
]
机构:
[1] Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
We report a case of cerebral aspergillosis which originated from the sphenoid sinus, and involved a progressive decrease of visual acuity, The neurological signs indicated a cavernous sinus invasion. After extensive intracranial surgery we treated the residual aspergillosis with a high oral dose of itraconazole (800 mg/d for 4 months, followed by 400 mg/d for 5 months). The neurological impairments of the patient gradually subsided with the resolution of the fungal lesion shown on MRI. The successful therapy indicated that itraconazole has a significant role in the treatment of advanced cerebral aspergillosis if it is used in high doses (16 mg/kg/d for adults).